"An appealing feature of [intermittent fasting] is that dieters do not have to focus on counting calories and restricting ...

DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced a key milestone in its ACESOT-1051 clinical trial, as the ...

On Wednesday morning, April 2, UH announced its partnership with Qure.AI, a global health tech startup, to use its AI solution qXR-LN technology. The tech acts as a second read on X-rays to catch lung ...

While Alzheimer’s disease is typically marked by a slow decline in memory and cognitive ability over a number of years, a ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Study published in World Neurosurgery confirms significant clinical benefit of Neo Medical's Force Control Technology in ...

A research team from the University of Minnesota Medical School has identified a strong predictor of ischemic stroke and ...

Clinical trials are essential in bringing innovative treatments to the market, but managing them efficiently requires cutting-edge technology. This is where IRT clinical trial companies play a crucial ...

The AdventHealth Neuroscience Institute is testing IDP-023 for primary or nonactive secondary progressive multiple sclerosis ...

Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort ...

A groundbreaking clinical trial on AI therapy chatbots shows significant reductions in depression, anxiety, and disordered ...

Candel Therapeutics (CADL) announced the publication of a manuscript reporting the results of a phase 1b clinical trial exploring safety and ...